Alliance for Pandemic Preparedness

Result for
Tag: Israel

January 29, 2021

The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization real-world evidence

[Pre-print, not peer-reviewed] The first dose of the BNT162b2 mRNA COVID-19 vaccine (Pfizer–BioNTech) is associated with an approximately 51% reduction in the incidence of PCR-confirmed SARS-CoV-2 infections at 13 to 24 days after immunization compared to the rate during the first 12 days. These findings are based on a retrospective cohort study in Israel (December…